Skip to content
healthcare.dev

ILEVRO

NDC 82667-400, nepafenac, suspension/ drops, from Harrow Eye, LLC.

Product NDC
82667-400
Status
Listed
Labeler
Harrow Eye, LLC
Dosage form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82667-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEPAFENAC3 mg/mL

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
82667-400-03826670400031 BOTTLE, PLASTIC in 1 CARTON (82667-400-03) / 3 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10f411d3-a81e-074a-e063-6294a90ab547
  • NADAC price for package 82667040003

    GET /v1/drugs/nadac/82667040003

Use it

Look up 82667-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82667-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82667-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.